Medical Research

Study shows antidepressant could do double duty as diabetes drug

University of Texas Medical Branch at Galveston researchers have discovered that the commonly used antidepressant drug paroxetine could also become a therapy for the vascular complications of diabetes.

Treat Type 1 to Treat Atherosclerosis

According to recent research, transplanting pancreatic islet cells may improve narrowed arteries in patients with type 1 diabetes.

Understanding pancreas size may help unlock cause of Type 1 diabetes

People at risk for Type 1 diabetes may have fewer insulin-producing “beta” cells than people not at risk, a finding that could help researchers shed light on what causes the disease.

Survivors of breast cancer more likely to develop diabetes

A major new study shows that post-menopausal survivors of breast cancer are more likely to develop diabetes than controls without breast cancer.

Fat transplant cures obesity and insulin resistance, offers hope to TII diabetics

Mice who received a transplant of brown fat into their abdominal cavity lost weight, improved their insulin sensitivity and metabolised glucose better says a recently published study.

New study shows Metmorfin is effective in treating very obese children

Treating obese children at risk for type 2 diabetes with the diabetes drug metformin was shown to be safe and effective.

New Therapy for Treating TII Diabetics With Stroke

A new possible therapy for treating brain damage among type 2 diabetics who have suffered from a stroke has been proposed by researchers from the Karolinska Institutet in Sweden.

BBC: Diabetes fuels heart failure risk

People with diabetes are up to 65% more likely to have heart failure, an analysis has found.

Positive Feedback System Provides New Piece of the Diabetes Puzzle

Researchers show that the cells that produce glucagon are stimulated by the hormone itself. A previous study by the same group demonstrated that this principle also applies to insulin.

Researchers ID gene that turns carbs into fat

A gene that helps the body convert that big plate of holiday cookies you just polished off into fat could provide a new target for potential treatments for fatty liver disease, diabetes and obesity.

Sugary Drinks Still Bad But What about Caffeine?

Results of a large new U.S. study confirm that sugary drinks are linked to a heightened risk of developing type 2 diabetes, but shed little light on whether caffeine helps or hinders the process.

How long for TII to come back after a bariatric surgery?

A study has been released that examines rates of diabetes remission following bariatric surgery over several years, and using data from three different surgery sites.

Treat Snoring to Avoid Deadly Heart Failure

Obstructive sleep apnea increases the risk of hypertension, arrhythmias, myocardial infarction, stroke, sudden cardiac death and heart failure.

New Evidence On How Compound Found in Red Wine Can Help Prevent Cancer

niversity of Leicester scientists will present groundbreaking new evidence about how a chemical found in red wine can help prevent cancer on December 5.

An inadequate diet during pregnancy predisposes the baby to diabetes

Experts already know that pregnant women should not eat for two. A study now insists on the importance of a healthy diet as a way of avoiding increased insulin and glucose levels in the child.

Study finds link between flu virus and TI diabetes onset

Researchers in Italy have discovered that the flu virus could contribute to the onset of diabetes. This finding could help scientists uncover a way to prevent some forms of this condition.

Moderate coffee consumption may reduce risk of diabetes by up to 25 percent

Drinking three to four cups of coffee per day may help to prevent type 2 diabetes according to research highlighted in a session report published by the Institute for Scientific Information on Coffee.

Type II linked to flame retardant exposure

Exposure to flame retardant chemicals may increase risk of Type II and metabolic syndrome.

mTOT Modulators may change the way doctors treat Type 2 diabetes

mTOT Modulators: These compounds have been shown to be safe, well-tolerated and effective at lowering glucose in phase 2 clinical studies involving people with Type 2 diabetes. Longer duration, more comprehensive clinical trials will proceed next year.

Nanoparticle Research Shows Promise for T1D and Other Autoimmune Diseases

In this research, the investigators used biodegradable nanoparticles containing MS-related antigen components to reset the immune system balance and create immune tolerance in an animal model of MS. JDRF provided partial support for this work because of its relevance to T1D immune therapies.